Active substanceAcetylcarnitineAcetylcarnitine
Similar drugsTo uncover
  • Karniteks
    capsules inwards 
  • Carnitine®
    capsules inwards 
    PIK-PHARMA, LLC     Russia
  • Dosage form: & nbspcapsules
    Composition:

    1 capsule contains:

    active substance: acetyl-L-carnitine hydrochloride 295 mg;

    Excipients: cellulose microcrystalline 17.8 mg, silicon dioxide colloid (aerosil) 6.8 mg, crospovidone, type A 17 mg, magnesium stearate 3.4 mg;

    hard gelatine capsules: titanium dioxide 1.25%, gelatin - up to 100%.

    Description:

    Hard gelatin capsules № 0 with a body and a lid of white color. The contents of capsules are white or almost white powder.

    Pharmacotherapeutic group:Metabolic means
    ATX: & nbsp

    N.06.B.X   Other psychostimulants and nootropic drugs

    Pharmacodynamics:

    Acetyl-L-carnitine (ALA) - a natural biologically active substance present in the body in various organs and tissues, including the central nervous system (CNS), is involved in the metabolism of fatty acids and carbohydrates. Acetyl-L-carnitine is a biologically active form of L-carnitine, a key substance in the process of energy production in the body. ALA is synthesized in the brain tissue, liver and kidneys from L-carnitine.

    ALA is an easily accessible substrate for triggering volatile metabolic processes in cells. Improves metabolism and energy supply of tissues.Due to the full energy supply of the body with less oxygen consumption by tissues, ALA protects brain tissue from oxygen starvation.

    The results of experimental studies showed that ALA has the ability to improve learning processes, indices of non-associative memory, to have a positive effect on memory functions in the conditions of the experimental model of Alzheimer's disease without causing side effects of a sedative and miorelaxing nature.

    Stimulates the synthesis of proteins and phospholipids to build cell membranes, improves cell repair processes. Has a protective effect in relation to the cells of the nervous system. ALA can accelerate the recovery of nerve cells in traumatic and endocrine damage to peripheral nerves.

    The noticeable effect of ALA has on the slowing down of the aging of cells and the maintenance of their work at the level of a young organism.

    Pharmacokinetics:

    Acetyl-L-carnitine is absorbed through the mucous membrane of the gastrointestinal tract (under the condition of its high concentration). In most tissues, including brain tissue,ALA comes from the bloodstream (except the liver and small intestine) in unchanged form. It is excreted from the body by the kidneys. When administered, the maximum concentration of the drug in the blood comes after 4 hours.

    Indications:

    In complex therapy.

    Decreased mental performance, to improve concentration and memory.

    Contraindications:

    -Increased sensitivity to acetylcarnitine or other components of the drug;

    - children's age till 18 years;

    - Pregnancy;

    - the period of breastfeeding.

    Pregnancy and lactation:

    Special studies on the possibility of use during pregnancy and during breastfeeding were not conducted.

    The use of the drug is contraindicated during pregnancy.

    For the duration of treatment, breastfeeding should be discontinued.

    Dosing and Administration:

    Inside, squeezed with enough water.

    A single dose of the drug for adults is usually 1-4 capsules, the daily dose is 6-12 capsules.

    The maximum course of treatment without a doctor's consultation is 1 month.

    After consultation with a doctor, the course of treatment can be extended.

    Side effects:

    Allergic reactions, gastrointestinal disorders, nausea, heartburn, anxiety, there may be a specific odor in urine, sweat and smell from the mouth.

    If any of the unwanted reactions listed in the manual is aggravated, or if you notice any other undesirable reactions not listed in the instructions, tell your doctor.

    Overdose:

    Currently, cases of overdose are not registered.

    Interaction:

    It is not recommended to apply simultaneously with acenocoumorol.

    Care must be taken when using with warfarin simultaneously.

    Effect on the ability to drive transp. cf. and fur:

    Does not affect the ability to drive vehicles and perform work that requires an increased concentration of attention and speed of psychomotor reactions.

    Form release / dosage:

    Capsules 295 mg.

    Packaging:

    By 10, 15, 20 or 30 capsules in a planar cell pack of film polyvinylchloride and aluminum foil printed lacquered.

    1, 2, 3, 4, 5, 6 contour mesh packages together with the instruction for use are placed in a pack of cardboard.

    Storage conditions:

    Keep in dry the dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:2 years. Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:LP-002693
    Date of registration:05.11.2014 / 09.11.2015
    Expiration Date:05.11.2019
    The owner of the registration certificate:OBOLENSKOE PHARMACEUTICAL ENTERPRISE, CJSC OBOLENSKOE PHARMACEUTICAL ENTERPRISE, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp14.12.2017
    Illustrated instructions
      Instructions
      Up